Literature DB >> 6356324

Maintenance treatment of patients with healed peptic ulcer with sucralfate, placebo and cimetidine.

M Libeskind.   

Abstract

Preliminary data from a randomised, placebo-controlled, multicenter study suggest that maintenance therapy with sucralfate reduces the rate of the recurrent ulceration in patients with recently healed ulcers.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6356324

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN： 0085-5928


  5 in total

1.  Sucralfate in the treatment and prevention of gastric ulcer: multicentre double blind placebo controlled study.

Authors:  A L Blum; H Bethge; J C Bode; W Domschke; G Feurle; K Hackenberg; B Hammer; W Hüttemann; M Jung; G Kachel
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

Review 2.  Assessing the safety of drugs for the long-term treatment of peptic ulcers.

Authors:  K G Wormsley
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

Review 3.  Drugs for the prevention of peptic ulcer recurrence.

Authors:  D W Piper
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

4.  Comparison of relapse rates and of mucosal abnormalities after healing of duodenal ulceration and after one year's maintenance with cimetidine or sucralfate: a light and electron microscopy study.

Authors:  F I Tovey; E M Husband; Y C Yiu; L Baker; G McPhail; M R Lewin; A P Jayaraj; C G Clark
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

Review 5.  Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.